Precision Medicine Group Competitors and Similar CompaniesClear all
Precision Medicine Group's competitors and similar companies include PPD, Patheon, Catalent and Almac Group.
 Precision Medicine Group Precision Medicine Group (PMG) is a company that specializes in advising clients on clinical trials, drug discovery, and commercialization. |  PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  Almac Group Almac Group is a company that provides a range of services across the drug development lifecycle. | ||
Founding Date | Founding Date 2012 | Founding Date 1985 | Founding Date 1993 | Founding Date 2007 | Founding Date 2002 |
Type | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Bethesda, US HQ | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Craigavon, GB HQ Athlone, IE Dundalk, IE Minato City, JP Singapore, SG Alderley Edge, GB Belfast, GB see more | |
Employees | Employees 4044% increase | Employees 24,5842% decrease | Employees 2,442 | Employees 12,6955% increase | Employees 4,7021% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $4.7b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) £735.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $1.7b (FY, 2020) | Cost of goods N/A | Cost of goods $3.4b (FY, 2024) | Cost of goods £474.7m (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit $3b (FY, 2020) | Gross profit N/A | Gross profit $953m (FY, 2024) | Gross profit £260.3m (FY, 2021) |
Net income | Net income N/A | Net income $160.6m (FY, 2020) | Net income N/A | Net income ($1b) (FY, 2024) | Net income £64.2m (FY, 2021) |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog $9.5b (Q3, 2021) | Backlog N/A | Backlog $2.5b (FY, 2023) | Backlog N/A |
Countries | Countries N/A | Countries 46 (FY, 2020) | Countries N/A | Countries 80 (FY, 2023) | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised $ 359.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 650m | Total funding raised $ 1m |
For sources of this data, please see the company profile
View Company Profiles
PPD
HQ
Wilmington, US
PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View company
Patheon
HQ
Durham, US
Patheon is a company that offers contract development and manufacturing solutions.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companyAlmac Group
HQ
Craigavon, GB
Almac Group is a company that provides a range of services across the drug development lifecycle.
View company